Integrating CRISPR Technology with Key Genetic Markers in Pancreatic Cancer: A New Frontier in Targeted Therapies
Pancreatic cancer is the result of mutations in crucial genetic markers like <i>KRAS</i> and <i>TP53</i> that make treatment challenging. This article discusses how CRISPR Cas9 technology can be combined with these markers to create treatments. CRISPR allows for the alteratio...
Saved in:
| Main Author: | |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2025-01-01
|
| Series: | SynBio |
| Subjects: | |
| Online Access: | https://www.mdpi.com/2674-0583/3/1/1 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|